Evidence map›Paper›PMID 27112763›Full record

ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2016

Current trends and future projections of hip fracture in South Korea using nationwide claims data.

Y-C Ha, T-Y Kim, A Lee, Y-K Lee, H-Y Kim, J-H Kim, C-M Park, S Jang

Abstract read
PubMed Publisher
In one paragraph

Article in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Long-term trends of osteoporotic hip fractures in South Korea: analysis of National Health Insurance Data from 2006 to 2022.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025
    Article
  7. The Korean hip fracture registry study.BMC musculoskeletal disorders · 2023
    Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Cost-effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in Malaysia.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Y-C HaDepartment of Orthopaedic Surgery, School of Medicine, Chung-Ang University, Seoul, Korea.
T-Y KimDepartment of Orthopaedic Surgery, School of Medicine, Hallym University, Anyang, Korea.
A LeeCollege of Pharmacy, Gachon University, 191 Hambangmoe-ro, Yeonsu-gu, Incheon, Korea.
Y-K LeeDepartment of Orthopaedic Surgery, Seoul National University Bundang Hospital, Seongnam, Korea.
H-Y KimDepartment of Internal Medicine, School of Medicine, Wonkwang University, Gunpo, Korea.
J-H KimBig Data Steering Department, National Health Insurance Service, Seoul, Korea.
C-M ParkDivision for Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Korea. chpark@neca.re.kr.
S JangCollege of Pharmacy, Gachon University, 191 Hambangmoe-ro, Yeonsu-gu, Incheon, Korea. smjang@gachon.ac.kr.ORCID 0000-0002-8771-8693

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledIncidence of hip fracture increased in Korean populations over age 50 between 2008 and 2012, and the number of fractures was predicted to increase by 1.4 times by 2025. This is important information for public health planning.

introductionThe purposes of this study were to evaluate the trends in the incidence and mortality of hip fracture between 2008 and 2012 and predict the number of hip fractures in Korea through 2025 using nationwide claims data.

methodsThe data managed by the National Health Insurance Service were used to identify the hip fractures in patients aged >50 years between 2008 and 2012. Projections of hip fractures were conducted using the Poisson distribution from 2016 to 2025 in Korea.

resultsThe incidence of hip fractures (per 100,000) increased by 14.1 % over the 5 years of the study, by 15.8 % in women and 10.9 % in men; the older age group showed a steep rise and shift in the incidence from 2008 to 2012. The cumulative mortality rates at 1 year after hip fractures were 17.2 % (3575/20,849) in 2008 and 16.0 % (4547/28,426) in 2012. Overall standardized mortality ratios (SMRs) for hip fracture were higher in men (11.93) than in women (11.22) and were higher than those in the general population in all age groups. In 2016, the total number of hip fractures was estimated to increase an overall of 1.4 times by 2025.

conclusionsThe incidence of hip fracture continues to increase, and the related mortality is still high, although it has decreased over time. The socioeconomic burden of hip fracture is expected to increase in Korea along with the increased estimated number of fractures. Nationwide strategies should include attempts to reduce the future socioeconomic burdens of hip fractures.

Indexed as

AgedAged, 80 and overAge DistributionFemaleForecastingHip FracturesHumansIncidenceMaleMiddle AgedNational Health ProgramsRepublic of KoreaSex DistributionHip fractureIncidenceMortalityOsteoporosisProjection

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.